Cargando…
The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway
LXR-623 (WAY-252623), a liver X receptor agonist, reduces atherosclerotic plaque progression and remarkably inhibits the proliferation of glioblastoma cells, owing to its brain-penetrant ability. However, the role of LXR-623 against the proliferation of other cancer cells and the underlying mechanis...
Autores principales: | Wan, Weijun, Hou, Yongying, Wang, Ke, Cheng, Yue, Pu, Xia, Ye, Xiufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416354/ https://www.ncbi.nlm.nih.gov/pubmed/30867411 http://dx.doi.org/10.1038/s41419-019-1440-5 |
Ejemplares similares
-
The liver X receptor agonist LXR 623 restricts flavivirus replication
por: Mlera, Luwanika, et al.
Publicado: (2021) -
Long Noncoding RNA LINC01125 Enhances Cisplatin Sensitivity of Ovarian Cancer via miR-1972
por: Guo, Jia, et al.
Publicado: (2019) -
Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats
por: Hou, Yongying, et al.
Publicado: (2018) -
LncRNA LINC01094 Promotes Cells Proliferation and Metastasis through the PTEN/AKT Pathway by Targeting AZGP1 in Gastric Cancer
por: Gong, Zhe, et al.
Publicado: (2023) -
Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR-367/PTEN axis
por: Mu, Xin, et al.
Publicado: (2019)